Anatomy and pathology of the kidney, Glomeruli and Tubular cells

Kidney International (1996) 49, 1575–1582; doi:10.1038/ki.1996.228

Cell-matrix interactions in the glomerular mesangium

Harald D Rupprecht1, Harald O Schöcklmann1 and R Bernd Sterzel1

1Medizinische Klinik IV, Universität Erlangen-Nürnberg, Erlangen, Germany

Correspondence: Prof Dr R B Sterzel, Medizinische Klinik IV, Universität Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany.

Top

Abstract

Cell-matrix interactions in the glomerular mesangium. Specific interactions between cells and components of the surrounding extracellular matrix (ECM) or underlying basement membrane have been shown to modulate cell behavior, including cellular responses to soluble regulator molecules. In addition to the long-recognized role of such interactions in cell localization, anchoring and differentiation during embryogenesis, they are also involved in diverse processes such as maintenance of tissue integrity, response of cells to mechanical stress, inflammatory response, wound healing, tumor cell growth and metastasis as well as apoptosis. Over the last several years, evidence has been reported that extensive "cross-talk" between glomerular mesangial cells (MCs), ECM molecules and soluble mediator substances also affects the proliferative and synthetic phenotype of MCs. This is likely to be relevant for the behavior of MCs during embryonic development, tissue repair and disease processes of glomeruli. The potential biologic and clinical relevance of cell-matrix interactions in the glomerulus makes their elucidation a challenging goal in current kidney research. In this brief review, we present selected aspects of recent investigations concerning the mesangial matrix and its interactions with MCs. In addition to results from cell culture studies, descriptive findings on abnormalities of the ECM and their potential role for the altered MC behavior in glomerular disease will also be discussed.

Top

References

  1. Abrass CK, Adcox MJ, Raugi GJ: Aging-associated changes in renal extracellular matrix. Am J Pathol 146:742–752, 1995 | PubMed | ISI | ChemPort |
  2. Sterzel RB, Schulze Lohoff E, Weber M, Goodman SL: Interactions between glomerular mesangial cells, cytokines, and extracellular matrix. J Am Soc Nephrol 2:S126–S131, 1992 | PubMed | ISI | ChemPort |
  3. Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andreani D, Galli G, Casini A, Bianchi S, Rotella CM: Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478–490, 1994 | PubMed | ISI | ChemPort |
  4. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536–542, 1994 | PubMed | ISI | ChemPort |
  5. Tamsma JT, van den Born J, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes HHPJ, van der Woude FJ: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313–320, 1994 | Article | PubMed | ISI | ChemPort |
  6. Davies M, Martin J, Thomas GJ, Lovett DH: Proteinases and glomerular matrix turnover. Kidney Int 41:671–678, 1992 | PubMed | ISI | ChemPort |
  7. Hagege J, Peraldi MN, Rondeau E, Adida C, Delarue F, Medcalf R, Schleuning WD, Sraer JD: Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells. Am J Pathol 141:117–128, 1992 | PubMed |
  8. Marti HP, McNeil L, Davies M, Martin J, Lovett DH: Homology cloning of rat 72 kD type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells. Biochem J 291:441–446, 1993
  9. Lovett DH, Johnson RJ, Marti HP, Martin J, Davies M, Couser WG: Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex mediated glomerulonephritis. Am J Pathol 141:85–98, 1992 | PubMed | ISI | ChemPort |
  10. Woods A, Couchman JR: Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell 5:183–192, 1994 | PubMed | ISI | ChemPort |
  11. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 120:577–585, 1993 | Article | PubMed | ISI | ChemPort |
  12. Petermann A, Fees H, Grenz H, Goodman SL, Sterzel RB: Polymerase chain reaction and focal contact formation indicate integrin expression in mesangial cells. Kidney Int 44:997–1005, 1993 | PubMed | ISI | ChemPort |
  13. Cosio FG, Sedmak DD, Nahman NSJ: Cellular receptors for matrix proteins in normal human kidney and human mesangial cells. Kidney Int 38:886–895, 1990 | PubMed | ISI | ChemPort |
  14. Adler S: Integrin receptors in the glomerulus: potential role in glomerular injury. (editorial) Am J Physiol 262:F697–F704, 1992 | PubMed | ISI | ChemPort |
  15. Hanks SK, Calalb MB, Harper MC, Patel SK: Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 89:8487–8491, 1992 | Article | PubMed | ChemPort |
  16. Parsons JT, Schaller MD, Hildebrand J, Leu TH, Richardson A, Otey C: Focal adhesion kinase: Structure and signalling. J Cell Sci Suppl 18:109–113, 1994
  17. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P: Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372:786–791, 1994 | PubMed | ISI | ChemPort |
  18. Chen HC, Guan JL: Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 91:10148–10152, 1994 | PubMed | ChemPort |
  19. Qwarnstrom EE, Ostberg CO, Turk GL, Richardson CA, Bomsztyk K: Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells. J Biol Chem 269:30765–30768, 1994 | PubMed | ISI | ChemPort |
  20. Couchman JR, Beavan LA, McCarthy KJ: Glomerular matrix: Synthesis, turnover and role in mesangial expansion. Kidney Int 45:328–335, 1994 | PubMed | ISI |
  21. Davies M: The mesangial cell: A tissue culture view. Kidney Int 45:320–327, 1994 | PubMed | ISI | ChemPort |
  22. Harris RC, Akai Y, Yasuda T, Homma T: The role of physical forces in alterations of mesangial cell function. Kidney Int 45(Suppl 45):S17–S21, 1994 | ISI | ChemPort |
  23. Lane TF, Sage EH: The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 8:163–173, 1994 | PubMed | ISI | ChemPort |
  24. Truong LD, Pindur J, Barrios R, D'Agati V, Lechago J, Suki W, Majesky M: Tenascin is an important component of the glomerular extracellular matrix in normal and pathologic conditions. Kidney Int 45:201–210, 1994 | PubMed | ISI | ChemPort |
  25. Clark EA, Brugge JS: Integrins and signal transduction pathways: The road taken. Science 268:233–239, 1995 | Article | PubMed | ISI | ChemPort |
  26. Bruijn JA, de Heer E: Adhesion molecules in renal diseases. Lab Invest 72:387–394, 1995 | PubMed | ISI | ChemPort |
  27. Ishimura E, Sterzel RB, Budde K, Kashgarian M: Formation of extracellular matrix by cultured rat mesangial cells. Am J Pathol 134:843–855, 1989 | PubMed | ISI | ChemPort |
  28. Simonson MS, Culp LA, Dunn MJ: Rat mesangial cell-matrix interactions in culture. Exp Cell Res 184:484–498, 1989 | Article | PubMed | ISI | ChemPort |
  29. Marinides GN, Suchard SJ, Mookerjee BK: Role of thrombospondin in mesangial cell growth: Possible existence of an autocrine feedback growth circuit. Kidney Int 46:350–357, 1994 | PubMed | ISI | ChemPort |
  30. Groggel GC, Marinides GN, Hovingh P, Hammond E, Linker A: Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol 258:F259–F265, 1990 | PubMed | ISI | ChemPort |
  31. Morita H, Shinzato T, David G, Mizutani A, Habuchi H, Fujita Y, Ito M, Asai J, Maeda K, Kimata K: Basic fibroblast growth factor-binding domain of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis. Lab Invest 71:528–535, 1994 | PubMed | ISI | ChemPort |
  32. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477–488, 1991 | PubMed | ISI | ChemPort |
  33. Ayo SH, Radnik RA, Glass WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185–F191, 1991 | PubMed | ISI | ChemPort |
  34. Cosio FG: Effects of high glucose concentrations on human mesangial cell proliferation. J Am Soc Nephrol 5:1600–1609, 1995 | PubMed | ISI | ChemPort |
  35. Anderson SS, Kim Y, Tsilibary EC: Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation. Kidney Int 46:1359–1367, 1994 | PubMed | ISI | ChemPort |
  36. Zhang Z, Vuori K, Reed JC, Ruoslahti E: The alpha5beta1 integrin supports survival of cells on fibronectin and upregulates bcl-2 expression. Proc Natl Acad Sci USA 92:6161–6165, 1995 | Article | PubMed | ChemPort |
  37. Marx M, Daniel TO, Kashgarian M, Madri JA: Spatial organization of the extracellular matrix modulates the expression of PDGF-receptor subunits in mesangial cells. Kidney Int 43:1027–1041, 1993 | ChemPort |
  38. Sterzel RB, Lovett DH, Foellmer HG, Perfeito M, Biemesderfer D, Kashgarian M: Mesangial cell hillocks: Nodular foci of exaggerated growth of cells and matrix in prolonged culture. Am J Pathol 125:130–140, 1986 | PubMed | ISI | ChemPort |
  39. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105–2116, 1994 | PubMed | ISI | ChemPort |
  40. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA: Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 141:1381–1396, 1992 | PubMed | ISI | ChemPort |
  41. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597–2601, 1993 | PubMed | ISI | ChemPort |
  42. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361–364, 1992 | Article | PubMed | ISI | ChemPort |
  43. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369–380, 1993 | PubMed | ISI | ChemPort |

Extra navigation

.
ADVERTISEMENT